FDA recall Z-1609-2024

Tandem Diabetes Care, Inc. · Class I · device

Product

t:connect mobile app used in conjunction with t:slim X2 insulin pump with Control-IQ technology

Reason for recall

During normal use, the mobile app version 2.7 may crash and be automatically relaunched by the iOS operating system. This cycle intermittently repeats, which leads to excessive Bluetooth communication that may result in pump battery drain and may lead to the pump shutting down sooner than typically expected. Pump shutdown will cause insulin delivery to suspend, which could lead to an under-delivery of insulin and may result in hyperglycemia, including severe hyperglycemia.

Distribution

US nationwide distribution including Puerto Rico.

Key facts

Status
Ongoing
Initiation date
2024-03-05
Report date
2024-05-15
Voluntary/Mandated
Voluntary: Firm initiated
Location
San Diego, CA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1609-2024